Vallexa Advisors analysis of the hospice M&A rebound in late 2025, referencing industry data showing the strongest quarter since 2021 and what it means for hospice valuation, seller readiness, and exit timing.
Related Articles
Key Drivers of Hospice Valuation Multiples in 2026
January 14, 2026
A Hospice Owner’s Guide to Valuation Multiples: How to Avoid Exit Pitfalls
December 30, 2025
Hospice Multiples in the Current Market
December 30, 2025